SE434844B - Analogiforfarande for framstellning av 4?721 epi-adriamycin i form av dess alfa- resp beta anomer - Google Patents

Analogiforfarande for framstellning av 4?721 epi-adriamycin i form av dess alfa- resp beta anomer

Info

Publication number
SE434844B
SE434844B SE7503215A SE7503215A SE434844B SE 434844 B SE434844 B SE 434844B SE 7503215 A SE7503215 A SE 7503215A SE 7503215 A SE7503215 A SE 7503215A SE 434844 B SE434844 B SE 434844B
Authority
SE
Sweden
Prior art keywords
respet
adriamycine
alfa
epi
preparation
Prior art date
Application number
SE7503215A
Other languages
English (en)
Other versions
SE7503215L (sv
Inventor
F Arcamone
Marco A Di
S Penco
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of SE7503215L publication Critical patent/SE7503215L/xx
Publication of SE434844B publication Critical patent/SE434844B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
SE7503215A 1974-03-22 1975-03-20 Analogiforfarande for framstellning av 4?721 epi-adriamycin i form av dess alfa- resp beta anomer SE434844B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1278374A GB1457632A (en) 1974-03-22 1974-03-22 Adriamycins

Publications (2)

Publication Number Publication Date
SE7503215L SE7503215L (sv) 1975-09-23
SE434844B true SE434844B (sv) 1984-08-20

Family

ID=10011048

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7503215A SE434844B (sv) 1974-03-22 1975-03-20 Analogiforfarande for framstellning av 4?721 epi-adriamycin i form av dess alfa- resp beta anomer

Country Status (18)

Country Link
US (1) US4058519A (sv)
JP (1) JPS5840555B2 (sv)
AT (1) AT338420B (sv)
AU (1) AU497500B2 (sv)
BE (1) BE826978A (sv)
CA (1) CA1046507A (sv)
CH (1) CH612947A5 (sv)
DE (1) DE2510866C3 (sv)
DK (1) DK153158C (sv)
ES (1) ES435833A1 (sv)
FR (1) FR2264555B1 (sv)
GB (1) GB1457632A (sv)
HK (1) HK882A (sv)
MY (1) MY103912A (sv)
NL (1) NL176635C (sv)
SE (1) SE434844B (sv)
SU (1) SU583763A3 (sv)
ZA (1) ZA751781B (sv)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133877A (en) * 1976-07-08 1979-01-09 Societa Farmaceutici Italia S.P.A. Anthracycline ethers and use therefor
US4201773A (en) * 1978-07-26 1980-05-06 The United States Of America As Represented By The Department Of Health, Education And Welfare 7-O-(2,6-Dideoxy-α-L-lyxo-hexopyranosyl)-daunomycinone, desmethoxy daunomycinone, adriamycinone, and carminomycinone
US4345068A (en) * 1979-11-22 1982-08-17 Farmitalia Carlo Erba S.P.A. Process for the preparation of 4'-epidaunorubicin, 3',4'-diepidaunorubicin, their doxorubicin analogs, and intermediates used in said process
ATE8401T1 (de) * 1980-11-01 1984-07-15 Farmitalia Carlo Erba S.P.A. Anthracyclin-glycoside, verfahren zu ihrer herstellung, zwischenprodukte und ihre herstellung und arzneimittel.
US4393052A (en) * 1980-11-01 1983-07-12 Farmitalia Carlo Erba S.P.A. Antitumor anthracycline glycosides, their preparation, intermediates therefor, and compositions and use thereof
US4562177A (en) * 1982-08-17 1985-12-31 The Ohio State University Research Foundation 3'-Amino-2' halo-anthracycline antibiotics
US4537882A (en) * 1984-05-10 1985-08-27 Ohio State University 4-Demethoxy-3'-desamino-2'-halo-anthracycline and pharmaceutical composition containing same
DE3500029A1 (de) * 1985-01-02 1986-09-04 Farmitalia Carlo Erba S.p.A., Mailand/Milano Anthracyclinester
GB2169284A (en) * 1985-01-05 1986-07-09 Erba Farmitalia 4'-Epidoxorubicin-14-esters
JPS61172891A (ja) * 1985-01-24 1986-08-04 フア−ミタリア・カルロ・エルバ・ソシエタ・ペル・アツイオ−ニ アントラサイクリン類エステルの製法
US5977082A (en) * 1985-08-02 1999-11-02 Pharmacia & Upjohn Company Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
GB8519452D0 (en) * 1985-08-02 1985-09-11 Erba Farmitalia Injectable solutions
US5124317A (en) 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.P.A. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5124318A (en) * 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.R.L. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
JPH034367Y2 (sv) * 1986-05-20 1991-02-05
SI0848009T1 (en) 1996-12-16 2000-12-31 Pharmachemie B.V. A process for preparing epirubicin or acid addition salts thereof from daunorubicin
NZ511093A (en) 1998-10-16 2003-04-29 Mercian Corp Crystallization of doxorubicin hydrochloride
KR100785966B1 (ko) * 2000-08-10 2007-12-14 동아제약주식회사 안트라싸이클린계 항암제인 에피루비신 및 약학적으로허용되는 그 염의 제조방법
KR100850408B1 (ko) * 2000-08-10 2008-08-04 동아제약주식회사 안트라싸이클린계 항암제인 에피루비신 및 약학적으로허용되는 그 염의 제조방법
AU2006207321B2 (en) 2005-01-21 2012-09-06 Astex Therapeutics Limited Pharmaceutical compounds
PL375008A1 (pl) 2005-05-12 2006-11-13 Institut National De La Sante Et De La Recherche Medicale, Inserm Nowe zastosowanie medyczne chlorowodorku epirubicyny
US8916552B2 (en) 2006-10-12 2014-12-23 Astex Therapeutics Limited Pharmaceutical combinations
WO2008044045A1 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Pharmaceutical combinations
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
SG172359A1 (en) 2008-12-23 2011-07-28 Pharmasset Inc Nucleoside phosphoramidates
KR20110104074A (ko) 2008-12-23 2011-09-21 파마셋 인코포레이티드 퓨린 뉴클레오시드의 합성
CL2009002208A1 (es) 2008-12-23 2010-10-29 Gilead Pharmasset Llc Un compuesto (2s)-2-((((2r,3r,4r,5r)-5-(2-amino-6-etoxi-9h-purin-9-il)-4-fluoro-3-hidroxi-4-metiltetrahidrofuran-2-il)metoxi)(hidroxi)fosforilamino)propanoico, inhibidores de la replicacion de arn viral; composicion farmaceutica; y su uso en el tratamiento de infeccion por hepatitis c, virus del nilo occidental, entre otras.
KR101715981B1 (ko) 2010-03-31 2017-03-13 길리애드 파마셋 엘엘씨 뉴클레오사이드 포스포르아미데이트
CN108473523B (zh) * 2016-01-11 2022-03-15 浙江海正药业股份有限公司 一种盐酸表柔比星的制备方法及其中间体
KR20230042756A (ko) 2016-03-15 2023-03-29 오리존 지노믹스 에스.에이. 고형 종양의 치료에 사용하기 위한 lsd1 억제제의 조합물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3356674A (en) * 1961-07-07 1967-12-05 Rikagaku Kenkyusho 3-c-hydroxymethyl-3, 5-didesoxy-l-lyxofuranose and its derivatives, and a process for the production thereof
US3427300A (en) * 1965-11-12 1969-02-11 Merck & Co Inc Anti-inflammatory steroid 2'-acetamido-2'-deoxy-glucoside compounds
YU33730B (en) * 1967-04-18 1978-02-28 Farmaceutici Italia Process for preparing a novel antibiotic substance and salts thereof
US3803124A (en) * 1968-04-12 1974-04-09 Farmaceutici It Soc Process for the preparation of adriamycin and adriamycinone and adriamycin derivatives
US3629231A (en) * 1968-05-23 1971-12-21 Biorex Laboratories Ltd Derivatives of glycyrrhetinic acid
US3651090A (en) * 1969-12-17 1972-03-21 Cutter Lab 1 3-dioxolan-4-yl-alkyl guanidines
FR2183710A1 (en) * 1972-05-06 1973-12-21 Farmaceutici Italia Daunomycin (hydrochloride) prepn - by reaction of daunomycinone with daunosamines, useful as antitumour agent and anti-leucemic

Also Published As

Publication number Publication date
AT338420B (de) 1977-08-25
CH612947A5 (sv) 1979-08-31
FR2264555A1 (sv) 1975-10-17
DE2510866C3 (de) 1980-08-14
JPS50126656A (sv) 1975-10-04
NL7502934A (nl) 1975-09-24
DK114475A (sv) 1975-09-23
DE2510866B2 (de) 1979-12-06
JPS5840555B2 (ja) 1983-09-06
SU583763A3 (ru) 1977-12-05
AU497500B2 (en) 1978-12-14
DK153158B (da) 1988-06-20
SE7503215L (sv) 1975-09-23
ES435833A1 (es) 1976-12-01
HK882A (en) 1982-01-22
ATA207475A (de) 1976-12-15
NL176635B (nl) 1984-12-17
AU7926375A (en) 1976-09-23
US4058519A (en) 1977-11-15
DE2510866A1 (de) 1975-10-02
ZA751781B (en) 1976-02-25
GB1457632A (en) 1976-12-08
FR2264555B1 (sv) 1980-01-11
DK153158C (da) 1989-01-16
CA1046507A (en) 1979-01-16
NL176635C (nl) 1985-05-17
MY103912A (en) 1993-10-30
BE826978A (fr) 1975-09-22

Similar Documents

Publication Publication Date Title
SE434844B (sv) Analogiforfarande for framstellning av 4?721 epi-adriamycin i form av dess alfa- resp beta anomer
SE419605B (sv) Forfarande for framstellning av undertrycksformad gjutform
FR2279380A1 (fr) Compositions cosmetiques anti-solaires
SE7513085L (sv) Forfarande for framstellning av etrar
IT1050758B (it) Disposizione per l applicazione di ingredienti
NL7503513A (nl) Werkwijze voor de bereiding van 7(beta)-acylamino- -7(alpha)-alkoxycefalosporinen en 6(beta)-acylamino-6ã(alpha)-al- koxypenicillinen.
SE7506160L (sv) Forfarande for framstellning av n-cykloalkylmetyldekahydroisokinoline
SE431207B (sv) Forfarande for framstellning av tiazolidinderivat
SE411453B (sv) Forfarande for framstellning av 3-fluorcefalosporiner
SE403477B (sv) Forfarande for famstellning av substituerade indoleniner
BG27233A3 (bg) Метод за получаване на 2-карбалоксиамино-5(6)-фенил- сулфонилокси-бензимидазоли
SE428015B (sv) Forfarande for framstellning av 3.4-dihydrokarbostyrilderivat
NL7509980A (nl) Werkwijze voor de bereiding van 7(beta)-acylamino- -7(alpha)-alkoxycefalosporinen.
RO65456A (ro) Procedeu pentru prepararea unor 6-metil-8-metilergoline substituite
SE416469B (sv) Forfarande for framstellning av aralkansyror innehallande dihydrofuran - eller dihydropyranringar
SE427925B (sv) Forfarande for framstellning av o-hydroxibensylalkoholer
SE7511801L (sv) Forfarande for framstellning av ympsampolymerisat
RO66137A (ro) Procedeu pentru prepararea clorhidratului de carnitina
JPS5123272A (ja) Karubamoiruarukokishi 3*44 jihidoroisokarubosuchirirujudotaino seizoho
SE431547B (sv) Forfarande for framstellning av 3-metylencefamsulfoxider
SE7512422L (sv) Forfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner
RO71797A (ro) Procedeu pentru prepararea unor tiocarbamati s-alchil substituiti
SE7507922L (sv) Forfarande for framstellning av 2(lh)-kinazolinonderivat.
SE434843B (sv) Analogiforfarande for framstellning av 4?721-epi-daunomycin i form av dess alfa- resp beta-anomer
RO67315A (ro) Procedeu pentru prepararea antibioticului 38295

Legal Events

Date Code Title Description
SPCF Application for supplementary protection certificate filed

Free format text: 7503215

NAL Patent in force

Ref document number: 7503215-1

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7503215-1

Format of ref document f/p: F

SPCG Supplementary protection certificate granted

Free format text: 9490109, 871211, EXPIRES: 20000322